Discontinuation report RIFADIN

Last updated on 2021-02-16 History
Report ID 134215
Drug Identification Number 02091887
Brand name RIFADIN
Common or Proper name Rifampin capsule
Company Name SANOFI-AVENTIS CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) RIFAMPIN
Strength(s) 150MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100
ATC code J04AB
ATC description DRUGS FOR TREATMENT OF TUBERCULOSIS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-01-28
Remaining supply date 2021-01-28
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2021-02-16 French Compare
v1 2021-02-16 English Compare